CD8A and neoplasm: Studies using mouse models have shown that FAP-CAR T cells can exhaust FAP-expressing stromal cells and inhibit tumor growth by producing immunostimulatory cytokines, promoting tumor cytolysis (48), and enhancing the anti-tumor response of endogenous CD8+ T cells (49).